LSL/MED/0246 The Supply of Tranexamic Acid Auto-Injector (TXA AI)
key details
| Value | £5,000,000 (£6,000,000 inc. VAT) |
|---|---|
| Status | planning |
| Category (CPV) | 33600000 +2 more |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-06a1ec |
description
LSL/MED/0246
Procurement description
Provide sufficient information to understand the scope of the procurement.
In April 2015 the MOD signed a thirteen year contract with Leidos Europe Ltd to provide the procurement and inventory management of commodity items (as well as the storage and distribution services) historically provided in-house by the Logistic Commodities and Services Operating Centre. Leidos, working with the MOD, will transform the way these services are delivered to ensure requirements continue to be met whilst providing best value for money for the department. The organisation delivering these services is known as Team Leidos.
Team Leidos would like to make markets aware that we are intending to investigate innovative approaches to fill our Supply of Tranexamic Acid Auto-Injector (TXA AI) requirements. We are actively seeking innovative, commercially viable solutions to meet this critical requirement. We invite industry partners to engage with us and bring forward novel approaches that can accelerate delivery, enhance operational effectiveness, and meet the evolving needs of Defence. We are interested in an Auto-Injector device containing 1g of Tranexamic Acid (TXA) in no greater than 3ml volume.
It is the aim of this Preliminary Market Engagement Notice (PMEN) to encourage companies, suppliers, or manufacturers to make us aware and provide as much information as they are comfortable with, to help decide the future strategy for the range.
Team Leidos wishes to generate interest, information and views with other companies to understand the current market innovation and gain useful intelligence that can help our requirement.
To request the PMEN documents please contact:
Name and Email address Christina.brice103@teamleidos.mod.uk
In the email request the documents related the Supply of Tranexamic Acid Auto-Injector (TXA AI). The documents will then be sent for completion and should be returned to the same email addresses before the deadline. Responses are required as soon as possible to inform next steps, but the PMEN will remain open until 27/07/2026
The value of this framework is estimated to be between £4,000,000 - £5,000,000
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 22 May 2026 | Preliminary market engagement (UK2) | Procurement Act 2023 | 048137-2026 |
| 22 May 2026 | Preliminary market engagement (UK2) | Procurement Act 2023 | 048143-2026 |
more from LEIDOS SUPPLY, LIMITED
- The Supply of Pollution Control Sorbents · £7,800,000 · 29 Jul 2026
- The Supply of Jerricans and Associated Consumables · £1,215,200 · 29 Jul 2026
- The Supply of Industrial Gases · £2,000,000 · 29 Jul 2026
- The Supply of Locks, Keys and Hinges (re-let) · £6,000,000 · 29 Jul 2026
- The Supply of Rope · £4,100,000 · 29 Jul 2026
- The Supply of Rock Salt · £2,000,000 · 29 Jul 2026
- The Supply of Fire Fighting Equipment; Spares: Repair · £8,000,000 · 29 Jul 2026
- The Supply of Plastic, Rubber and Cork Sheeting · £2,000,000 · 29 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.